drugset / Trial / NCT02495779
Feasibility of Short-Term PrEP Uptake for MSM With Episodic High-Risk for HIV
Completed
54 enrolled
James Egan
Fenway Community Health · collabNational Institute of Mental Health (NIMH) · collab
NaSingle-groupOpen-labelPrevention
Summary
This study is designed to investigate the acceptability, perceived need and uptake of short-term episodic Pre-Exposure Prophylaxis (PrEP) for HIV prevention among men who have sex with men (MSM). The overall objective is to determine the feasibility of a clinic-based Epi-PrEP implementation pilot project for 50 MSM (25/each of the 2 study sites) who report occasional condomless sex and who anticipate a period of high-risk while away from home (e.g. vacation) during the study period.
Timeline
- Start
- 2015-07
- Primary completion
- 2017-11
- Completion
- 2017-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tenofovir | Small molecule | — | — |
| Subject | emtricitabine | Other / unclassified | — | — |